Title: To Study the Therapeutic Efficacy of the Glycolic Acid Peeling, Salicylic Acid Peeling and Micro-Dermabrasion in the Treatment of Melasma

Authors: Akshy Kumar, Mukul Sharma, Dr Rita Vora

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i5.82

Abstract

Background: Melasma is an acquired increased pigmentation of the skin, characterized by gray-brown symmetrical patches, mostly in the sun-exposed areas of the skin.

Methods: The present study was carried out in the department of dermatology in a teaching institute. A total of 60 patients were enrolled for the study over a period of one year.

Results: In those who were treated with GA peeling; 15 % had excellent response, 35 % had good response, 40% had fair response and only 10% had poor response. Out of total 20 patients treated with SA peeling 10% had excellent response, 15% had good response, 45% had fair response and 30% had poor response. In response with micro-dermabrasion no patient had excellent response while good response was seen in 20%, fair   response in 40% and poor response in another 40% patients.

Conclusion: All three agents were effective and safe in Indian patients, with Glycolic Acid Peel being better effect on melasma patients.

Keywords: Therapeutic, Melasma, Pregnancy.

References

  1. Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009; 54:303–92. 
  2. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25:343–522.
  3. Estrada-Castanon R, Torres-Bibiano B, Alarcon-Hernandez H. Epidemiologia cutanea en dos sectores de atencion medica en Guerrero, Mexico. Dermatologia Rev Mex. 1992;36:29–34.
  4. Failmezger C. Incidence of skin disease in Cazco, Peru. Int J Dermatol. 1992;36:29–34.
  5. Goh CL, Dlova CN. A retrospective Study on the clinical presentation and treatment outcome of melasma in a tertiary dermat-ological referral centre in Singapore. Singapore Med J. 1999;40:455–8.
  6. Katsambas AD, Stratigos AJ, Lotti TM. Melasma. In: Katsambas AD, Lotti TM, editors. European handbook of dermatological treatments.2nd ed. Berlin: Springer; 2003. pp. 336–41.
  7. Resnik S. Melasma induced by oral contraceptive drug. JAMA. 1967;199:601–5. 
  8. Vazquez M, Maldonado H, Benmaman C. Melasma in men, a clinical and histological study. Int J Dermatol. 1988;27:25–7. 
  9. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC., Jr Melasma: A clinical, light microscopic, ultrastructural and immunoflorescence study. J Am Acad Dermatol. 1981;4:698–710.
  10. Pathak MA. Clinical and therapeutic aspects of Melasma: An overview. In: Fitz Patrick TB, Wick MM, Toda K, editors. Brown melanoderma. Tokyo: University of Tokyo Press; 1986. pp. 161–72.
  11. Katasambas A, Antoniou C. Melasma: Classification and treatment. J Eur Acad Dermatol Venereol. 1995;4:217–23.
  12. Thappa DM. Melasma (chloasma): A review with current treatment options. Indian J Dermatol. 2004;49:165–76.
  13. Goh CL, Dlova CN. A retrospective Study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singa-pore. Singapore Med J. 1999;40:455–8.
  14. Nicolaidou E, Antoniou C, Katsambas AD. Origin, clinical presentation, and diagnoses of facial hypermelanoses. (8).Dermatol Clin. 2007;25:321–6.

Corresponding Author

Akshy Kumar

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile-9887480200